Federal Circuit affirms Latuda decision in Sumitomo clash

19-04-2018

Federal Circuit affirms Latuda decision in Sumitomo clash

ericsphotography / iStockphoto.com

The US Court of Appeals for the Federal Circuit affirmed a lower court’s claim construction of a patent which covers Sunovion’s schizophrenia and bipolar depression drug Latuda on Monday, April 16. 


LSIPR